Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,780 | -179,389 | 87,226 | 71,587 | 81,923 |
| Depreciation Amortization | 57,697 | 186,178 | 17,368 | 41,213 | 21,387 |
| Income taxes - deferred | -12,914 | -23,329 | 11,734 | -5,694 | -4,097 |
| Other Working Capital | -149,522 | 470,748 | -30,590 | -253,279 | -80,945 |
| Other Operating Activity | 21,960 | 4,693 | 9,753 | 24,916 | 4,455 |
| Operating Cash Flow | $-126,559 | $458,901 | $95,491 | $-121,257 | $22,723 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -668 | -995 | -2,683 | -3,497 | -2,754 |
| Net Acquisitions | N/A | N/A | -3,376 | 29,050 | -189,269 |
| Other Investing Activity | -340 | -19 | 0 | -2,000 | 0 |
| Investing Cash Flow | $-1,008 | $-1,014 | $-6,059 | $23,553 | $-192,023 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 460,000 | N/A | N/A | N/A | 245,693 |
| Debt Repayment | -339,458 | N/A | -37,531 | -7,700 | -10,573 |
| Common Stock Issued | 1,375 | 216 | 8,491 | 9,892 | 328 |
| Dividend Paid | -3,448 | -18,601 | -7,238 | -2,367 | N/A |
| Other Financing Activity | -38,341 | -24,650 | -28,164 | 0 | 0 |
| Financing Cash Flow | $80,128 | $-43,035 | $-64,442 | $-175 | $235,448 |
| Beginning Cash Position | 491,885 | 77,033 | 52,043 | 149,922 | 83,774 |
| End Cash Position | 444,446 | 491,885 | 77,033 | 52,043 | 149,922 |
| Net Cash Flow | $-47,439 | $414,852 | $24,990 | $-97,879 | $66,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | -126,559 | 458,901 | 95,491 | -121,257 | 22,723 |
| Capital Expenditure | -668 | -995 | -2,683 | -3,497 | -2,754 |
| Free Cash Flow | -127,227 | 457,906 | 92,808 | -124,754 | 19,969 |